The effect of misoprostrol in reduction of postpartum hemorrhage

Comparison of misoprostrol and oxytocin in reduction of postpartum hemorrhage

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812223548N1

Enrollment

300

Registered

2010-05-29

Start date

2009-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reduction of postpartum haemorrhage. Other immediate postpartum haemorrhage

Interventions

Intervention 1: 10 IU oxytocin administration. Intervention 2: 400 microgram misoprostrol administration.

Treatment - Drugs

10 IU oxytocin administration

400 microgram misoprostrol administration

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: pregnant women with singleton pregnancy, cephalic, spontaneous and induced delivery, term pregnancy. Exclusion criteria: instrumental delivery, TL during 24h after delivery, past history of abruption placenta, history of asthma, coagulopathy, history of postpartum hemorrhage, history of C/S.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reduction of postpartum hemorrhage. Timepoint: in admission at labour and 24h after delivery. Method of measurement: blood sampling and CBC.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimindokht Moradi

Qazvin University Of Medical Sciences

simindokht56@yahoo.com+98 28 1366 6770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026